戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  was compared with placebo were analysed for measles antibodies.
2  were also associated with reduced levels of measles antibodies.
3 protected from measles infection by maternal measles antibodies.
4  1967-1976 had significantly lower levels of measles antibody (92.4% [95% CI, 90.8%-93.9%]) than did
5 assess serologic response, seroprevalence of measles antibody among children aged 4-6 years in 1995 w
6                            Residual maternal measles antibodies and immunologic immaturity dampen imm
7  children vaccinated in presence of maternal measles antibody and 14.5 per 1000 person-years without
8                                Low levels of measles antibodies at birth render children susceptible
9                                              Measles antibody concentrations before and 8, 32, and 80
10 subjects in this study were seropositive for measles antibody, despite the fact that almost 20% of ch
11     In a combined analysis, children who had measles antibody detected when they received their first
12 cases had clinically compatible symptoms and measles antibody detection in cerebrospinal fluid (CSF)
13      We investigated predictors of levels of measles antibodies in newborns in rural Kenya.
14 aria infection was associated with levels of measles antibodies in newborns.
15  maternal HIV infection may reduce levels of measles antibodies in newborns.
16 ay was used to measure the seroprevalence of measles antibody in NHANES participants 6-49 years of ag
17                 464 children with detectable measles antibody in their sample before vaccination were
18 eferred electrochemical method for detecting measles-antibodies in label-free manner.
19 rvived and returned for follow-up maintained measles antibody levels >or=120 mIU/mL, compared with 89
20 man leukocyte antigen (HLA) homozygosity and measles antibody levels was assessed in a volunteer grou
21 port capacity at delivery [fetal to maternal measles antibody (MMA) ratio].
22 ibody and 14.5 per 1000 person-years without measles antibody (MRR, 0.29; 95% CI, .09-.91).
23 g HIV-uninfected children, the difference in measles antibody prevalence at age 12 months between one
24               Among HIV-uninfected children, measles antibody prevalence was lower among 1- than 2-do
25             Previously, we demonstrated that measles antibody prevalence was lower at age 12 months a
26 ts born to mothers with history of wild-type measles, antibody responses among children born to vacci
27            Children previously identified as measles antibody seronegative or equivocal after 1 dose
28 130 children reimmunized, 106 (81.5%) became measles antibody seropositive, but 24 children (18.5%) r
29 d 35.1% (95% CI, 9.8%-53.2%) lower levels of measles antibodies than did those born to HIV-uninfected
30                                              Measles antibody titers were measured by enzyme-linked i
31                The highest seroprevalence of measles antibody was in non-Hispanic blacks (98.6% [95%
32                                  Testing for measles antibody was included in the National Health and
33                                              Measles antibody was measured a minimum of 6 weeks later
34 Multivariate analysis showed that absence of measles antibody was significantly associated with young
35 urvival if given in the presence of maternal measles antibody, we reanalyzed data from 2 previously p
36                             Children without measles antibodies were more likely to have never receiv

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。